Johnson & Johnson's one-dose COVID vaccine promising in early trial
A single-shot COVID-19 vaccine from Johnson & Johnson has shown very strong results in early clinical trials, potentially providing a significant boost to U.S. vaccination efforts.
Jan 14, 2021
0
54